½üÈÕ£¬¿ç¹úÒ©ÆóÂÞÊÏÐû²¼£¬ÒÑÓëZealand Pharma¾ÍÒ»¿îÒȵíËØÀàËÆÎïPetrelintide´ï³ÉºÏ×÷¡£¸ù¾ÝÐÒ飬˫·½½«¹²Í¬ºÏ×÷¿ª·¢Petrelintide¡£Íƹ㷽Ã棬ÃÀ¹úºÍÅ·ÖÞÊг¡ÓÉË«·½¹²Í¬Íƶ¯£¬ÊÀ½çÆäËûµØÇøµÄÍƹãȨÓÉÂÞÊÏËùÓС£ Zealand Pharma½«»ñµÃ16.5ÒÚÃÀÔªµÄÇ°ÆÚÏֽ𸶿ÆäÖаüÀ¨ÔÚÐÒéÇ©¶©Ê±Ö§¸¶µÄ14ÒÚÃÀÔªÒÔ¼°ÔÚºÏ×÷µÄÇ°Á½¸öÖÜÄê·Ö±ðÖ§¸¶µÄ2.5ÒÚÃÀÔª¡£ ´ËÍ⣬Zealand Pharma»¹ÓÐ×ʸñ»ñµÃÓëPetrelintideµ¥Ò»ÁÆ·¨¢óÆÚÊÔÑéÆô¶¯Ïà¹ØµÄ12ÒÚÃÀÔª¿ª·¢Àï³Ì±®¸¶¿î£¬ÒÔ¼°»ùÓÚÏúÊÛµÄ24ÒÚÃÀÔªÀï³Ì±®¸¶¿î£¬×ܸ¶¿î¶î×î¸ß¿É´ï53ÒÚÃÀÔª¡£ Ãé׼пî¼õ·ÊÒ© ´Ë´Î½»Ò×µÄ×î´óÁÁµãÔÚÓÚPetrelintideÔÚ¼õ·ÊÊг¡ÉϵÄDZÁ¦¡£ ½üÄêÀ´£¬GLP-1ÀàÒ©ÎïÔÚ¼õÖØÉϵÄÁÆЧ£¬ÈÃÆä·çÃÒÈ«Çò¡£ÀñÀ´ºÍŵºÍŵµÂÕâÁ½¼Ò¿ç¹úÒ©ÆóÒ²Òò´Ë¶ø׬µÄÅèÂú²§ÂúÊÐÖµìÉý¡£ ¾ÝÀñÀ´2024Äê²Æ±¨£¬¹«Ë¾È¥ÄêÈ«ÄêÓªÊÕ450.43ÒÚÃÀÔª£¬Í¬±ÈÔö³¤32%£»¾»ÀûÈó105.9ÒÚÃÀÔª£¬Í¬±ÈÔö³¤106%¡£ÆäÖУ¬Ìæ¶û²´ëÄ£¨°üÀ¨¼õÖØ°æºÍ½µÌǰ棩ºÏ¼ÆÏúÊÛ¶î´ï164.66ÒÚÃÀÔª£¬ÔÚ×ÜÊÕÈëÖÐÕ¼±È³¬¹ý36%¡£ ´Ë´Î£¬ÂÞÊÏÊÕ¹ºµÄPetrelintideÓëÏÖÓеÄ˾ÃÀ¸ñ³ëĵÈGLP-1Ò©Îï»úÖƲ»Í¬£¬ËüÊÇÒ»ÖÖÊÊÓÃÓÚÿÖÜÒ»´ÎƤÏÂ×¢ÉäµÄ³¤Ð§ÒȵíËØÀàËÆÎÄܹ»ÓëÆäËûëÄÀàÒ©ÎïÁªºÏÅäÖƺÍÁªºÏ¸øÒ©¡£ ÒȵíËØÊÇÓÉÒÈÏÙ¦Âϸ°û²úÉú£¬²¢ÓëÒȵºËØÔÚÉãÈëÓªÑøÎïÖÊʱ¹²Í¬·ÖÃÚ¡£ÒȵíËØÊÜÌ弤»îÒѱ»Ö¤Ã÷ͨ¹ý»Ö¸´¶Ô±¥¸¹¸Ð¼¤ËØÊÝËصÄÃô¸ÐÐÔÀ´¼õÉÙÌåÖØ£¬´Ó¶ø²úÉú¸ü¿ìµÄ±¥¸¹¸Ð¡£ Ä¿Ç°£¬Petrelintide´¦ÓÚ¢òbÆÚÁÙ´²ÊÔÑéÖС£ÏÖÓеÄÁÙ´²Êý¾ÝºÍÁÙ´²Ç°Êý¾Ý±íÃ÷£¬PetrelintideÓпÉÄÜÌṩÓëGLP-1ÊÜÌ弤¶¯¼ÁÏ൱µÄ¼õ·ÊЧ¹û£¬µ«¾ßÓиüºÃµÄÄÍÊÜÐÔ£¬´Ó¶øΪ»¼ÕßÌṩ¸üºÃµÄÌåÑéºÍ¸ßÖÊÁ¿µÄ¼õ·ÊЧ¹û¡£ ÂÞÊÏÖÆÒ©Ê×ϯִÐйÙÌØÀÙɯ¡¤¸ñÀ׶òÄ·£¨Teresa Graham£©±íʾ£º¡°ag¿·¢_¿·¢Ò»´¥¼´·¢ºÜ¸ßÐËÓëZealand PharmaºÏ×÷¿ª·¢ÕâÖÖÓÐÇ°¾°µÄÖÎÁÆ·½·¨£¬Ï£ÍûΪ·ÊÅÖºÍÏà¹Ø²¢·¢Ö¢»¼ÕßÌṩеÄÖÎÁÆÑ¡Ôñ¡£ag¿·¢_¿·¢Ò»´¥¼´·¢¹²Í¬ÖÂÁ¦ÓÚ½«Petrelintide¿ª·¢ÎªÎ´À´µÄ»ùʯÁÆ·¨¡£¡± ³ýµ¥Ò»ÁÆ·¨Í⣬Petrelintide»¹½«ÓëÂÞÊϵÄË«ÖØGLP-1/GIPÊÜÌ弤¶¯¼ÁCT-388×éºÏ¡£CT-388ÊÇÂÞÊϵÄ×ÔÑйÜÏߣ¬ÕýÔÚ¿ª·¢ÓÃÓÚÖÎÁÆ·ÊÅÖºÍ2ÐÍÌÇÄò²¡£¨T2D£©¡£CT-388Ä¿Ç°ÕýÔÚ2bÆÚÁÙ´²ÊÔÑéÖÐÑо¿£¬ÊÊÓ¦Ö¢Õë¶ÔÓкÍûÓÐ2ÐÍÌÇÄò²¡µÄ³¬ÖØ/·ÊÅÖÈËȺ¡£ ÂÞÊÏ·½Ãæ±íʾ£¬PetrelintideºÍCT-388µÄ²úÆ·×éºÏ½«¼ÓÇ¿²¢À©´óÂÞÊÏÔÚÐÄѪ¹Ü¡¢ÉöÔàºÍ´úл£¨CVRM£©¼²²¡ÁìÓòµÄÑз¢¹ÜÏß¡£ÕâÖÖ×éºÏÓÐÍûÌṩͬÀà×î¼ÑµÄÁÆЧ£¬Í¬Ê±¿ÉÄÜÌṩ¸üºÃµÄÄÍÊÜÐÔ¡£ ÕýÅàÓý¶à¿îÖØ°õÒ©Îï ´ÓÂÞÊÏ2024Äê·¢²¼µÄ²Æ±¨Êý¾ÝÀ´¿´£¬2024ÄêÈ«Ä깫˾ʵÏÖÓªÊÕ604.95ÒÚÈðÊ¿·¨ÀÉ£¨Ô¼ºÏ683.96ÒÚÃÀÔª£©£¬Í¬±ÈÔö³¤7%¡£ÆäÖУ¬ÖÆÒ©ÒµÎñÈ«ÄêÓªÊÕ461.71ÒÚÈðÊ¿·¨ÀÉ£¨Ô¼ºÏ522ÒÚÃÀÔª£©£¬Í¬±ÈÔö³¤8%£»Õï¶ÏÒµÎñÈ«ÄêÓªÊÕ143.24ÒÚÈðÊ¿·¨ÀÉ£¨Ô¼ºÏ161.94ÒÚÃÀÔª£©£¬Í¬±ÈÔö³¤4%¡£ ÖйúÇø·½Ã棬ÂÞÊÏÖÆÒ©ÒµÎñÓªÊÕ29.26ÒÚÈðÊ¿·¨ÀÉ£¨Ô¼ºÏ33.08ÒÚÃÀÔª£©£¬Í¬±ÈÔö³¤6%£»Õï¶ÏÒµÎñÓªÊÕ24.02ÒÚÈðÊ¿·¨ÀÉ£¨Ô¼ºÏ27.15ÒÚÃÀÔª£©£¬Í¬±ÈÔö³¤1%£»Á½ÏîºÏ¼Æ¹²Îª53.28ÒÚÈðÊ¿·¨ÀÉ£¨Ô¼ºÏ60.24ÒÚÃÀÔª£©¡£ ϸ·Ö²úÆ·ÉÏ£¬¹«Ë¾¹ýÈ¥Ò»Äê¹²ÓÐ17¿îÒ©Îï³ÉΪ¡°ÖØ°õÕ¨µ¯¡±£¨ÄêÏúÊ۶10ÒÚÃÀÔªµÄÒ©Î¡£ÆäÖУ¬ÑÛ¿ÆË«¿¹Ò©Î¡ª·¨ÈðÎ÷µ¥¿¹£¨Vabysmo£©Ôö³¤Ç¿¾¢£¬È¥ÄêÈ«ÄêÏúÁ¿Ôö³¤·ù¶È´ï68%¡£Ä¿Ç°£¬VabysmoÒÑ»ñÅúÈý´óÑÛµ×¼²²¡ÊÊÓ¦Ö¢£¬°üÀ¨ÐÂÉúѪ¹ÜÐÔ£¨ÊªÐÔ£©ÄêÁäÏà¹ØÐԻư߱äÐÔ£¨nAMD£©¡¢ÌÇÄò²¡ÐԻưßË®Ö×£¨DME£©ºÍÊÓÍøĤ¾²Âö×èÈû£¨RVO£©¡£ Æä´ÎÊÇÅÁÍ×ÖéÇúÍ×Öéµ¥¿¹Æ¤ÏÂ×¢Éä¼ÁPhesgo£¬¸ÃÒ©È¥ÄêÈ«ÄêÏúÊÛ¶îʵÏÖ62%µÄÔö³¤¡£È¥Äê1Ô£¬¸ÃÒ©ÒÑ»ñ¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾ÖÅú×¼£¬ÓÃÓÚÖÎÁƳÉÈËHER2ÑôÐÔÔçÆÚºÍתÒÆÐÔÈéÏÙ°©»¼Õß¡£¾ÝÂÞÊϽéÉÜ£¬¡°ÅÁÍ×Öé¡¢ÇúÍ×ÖéË«¼ÁºÏÒ»¡±Ö»Ðè5-8·ÖÖӾͿÉÒÔÍê³ÉÖÎÁÆ£¬¸ïÐÂÈéÏÙ°©°ÐÏòÖÎÁÆ´«Í³Ä£Ê½¡£ ´ÓÄ걨Öв»ÄÑ·¢ÏÖ£¬ÂÞÊÏÈ¥ÄêÔÚÑз¢ÉÏÒ²²ÉÈ¡Á˽÷É÷µÄ²ßÂÔ¡£È¥Ä깫˾¹²¼ÆɾµôµÄÊ®Ìõ¹ÜÏß¡£ÆäÖÐ6¸ö´¦ÓÚ¢ñÆÚÁÙ´²ÊÔÑé½×¶Î£¬2¸ö´¦ÓÚ¢òÆÚÁÙ´²ÊÔÑé½×¶Î£¬»¹ÓÐ2¸ö´¦ÓÚ¢óÆÚÁÙ´²ÊÔÑé½×¶Î¡£ÖÕÖ¹µÄÁ½Ïî¢óÆÚÁÙ´²Ñо¿ÎªTIGITµ¥¿¹tiragolumabÁªÓÿ¹PD-L1µ¥¿¹TecentriqÒ»ÏßÖÎÁÆPD-L1¸ß±í´ï·ÇСϸ°û·Î°©µÄÑо¿ºÍ¸ÃÒ©Ò»ÏßÖÎÁÆʳ¹ÜÁÛ״ϸ°û°©µÄÑо¿¡£ Õ¹ÍûδÀ´£¬ÂÞÊÏÔ¤¼Æ»áÓÐ7¸öÒÔÉÏDZÔÚ·åÖµÏúÊ۶30ÒÚÈðÊ¿·¨ÀɵÄзÖ×ÓʵÌå³öÏÖ£¬ÆäÖаüÀ¨ÉÏÊöÌá¼°µÄCT-388ÒÔ¼°ÁíÁ½¿î¼õ·ÊÒ©CT-996ºÍCT-868¡£ ÆäÖУ¬CT-996ÊÇÒ»¿î¿Ú·þС·Ö×ÓGLP-1ÊÜÌ弤¶¯¼Á£¬CT-868ÊÇÒ»¿îƤÏÂ×¢ÉäGLP-1R/GIPRË«Öؼ¤¶¯¼Á¡£ÂÞÊÏÔÚÄ걨ÖбíʾÕâÁ½Ìõ¹ÜÏß·Ö±ðÔÚ¢ñÆÚÁÙ´²ÊÔÑéºÍ·ÊÅÖ¢ñbÆÚÁÙ´²ÊÔÑéÖÐչʾ³öÁË»ý¼«µÄ½á¹û¡£